会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • DNA encoding human cysteine protease
    • 编码人半胱氨酸蛋白酶的DNA
    • US5840562A
    • 1998-11-24
    • US928613
    • 1997-09-12
    • Dinh DiepScott Michael BraxtonAngelo M. Delegeane
    • Dinh DiepScott Michael BraxtonAngelo M. Delegeane
    • C12N9/64C12N9/48C07H21/04
    • C12N9/6472
    • The present invention provides a polynucleotide (ncp) which identifies and encodes a novel cysteine protease (NCP) expressed in cells of both the adrenal gland and human umbilical vein endothelium. The present invention also provides for antisense molecules and oligomers designed from the nucleotide sequence or its antisense. The invention further provides genetically engineered expression vectors and host cells for the production of purified NCP peptide, antibodies capable of binding to NCP, inhibitors which bind to NCP and pharmaceutical compositions based on NCP specific antibodies or inhibitors. The invention specifically provides for diagnostic assays based on altered ncp expression and which allow identification of such a condition. These assays utilize probes designed from ncp encoding or controlling nucleic acid sequences or antibodies specific for the NCP.
    • 本发明提供了鉴定和编码在肾上腺和人脐静脉内皮的细胞中表达的新型半胱氨酸蛋白酶(NCP)的多核苷酸(ncp)。 本发明还提供由核苷酸序列或其反义设计的反义分子和寡聚体。 本发明进一步提供用于产生纯化的NCP肽,能够结合NCP的抗体,结合NCP的抑制剂和基于NCP特异性抗体或抑制剂的药物组合物的遗传工程表达载体和宿主细胞。 本发明特别提供了基于改变的ncp表达并允许鉴定这种病症的诊断测定法。 这些测定使用从ncp编码或控制核酸序列或针对NCP特异的抗体设计的探针。
    • 8. 发明授权
    • Human cysteine protease
    • 人半胱氨酸蛋白酶
    • US6007997A
    • 1999-12-28
    • US193524
    • 1998-11-17
    • Dinh DiepScott Michael BraxtonAngelo M. Delegeane
    • Dinh DiepScott Michael BraxtonAngelo M. Delegeane
    • C12N9/64C12Q1/68C07H21/04C12N15/85
    • C12N9/6472
    • The present invention provides a polynucleotide (ncp) which identifies and encodes a novel cysteine protease (NCP) expressed in cells of both the adrenal gland and human umbilical vein endothelium. The present invention also provides for antisense molecules and oligomers designed from the nucleotide sequence or its antisense. The invention further provides genetically engineered expression vectors and host cells for the production of purified NCP peptide, antibodies capable of binding to NCP, inhibitors which bind to NCP and pharmaceutical compositions based on NCP specific antibodies or inhibitors. The invention specifically provides for diagnostic assays based on altered ncp expression and which allow identification of such a condition. These assays utilize probes designed from ncp encoding or controlling nucleic acid sequences or antibodies specific for the NCP.
    • 本发明提供了鉴定和编码在肾上腺和人脐静脉内皮的细胞中表达的新型半胱氨酸蛋白酶(NCP)的多核苷酸(ncp)。 本发明还提供由核苷酸序列或其反义设计的反义分子和寡聚体。 本发明进一步提供用于产生纯化的NCP肽,能够结合NCP的抗体,结合NCP的抑制剂和基于NCP特异性抗体或抑制剂的药物组合物的遗传工程表达载体和宿主细胞。 本发明特别提供了基于改变的ncp表达并允许鉴定这种病症的诊断测定法。 这些测定使用从ncp编码或控制核酸序列或针对NCP特异的抗体设计的探针。
    • 9. 发明授权
    • Homolog of rat elastase IV derived from human pancreas
    • 来自人胰腺的大鼠弹性蛋白酶IV的同源物
    • US5856109A
    • 1999-01-05
    • US966319
    • 1997-11-07
    • Scott M. BraxtonDinh DiepAngelo M. Delegeane
    • Scott M. BraxtonDinh DiepAngelo M. Delegeane
    • A61K38/00C12N9/64G01N33/53C07K1/00
    • C12N9/6424A61K38/00
    • The present invention provides nucleotide and amino acid sequences that identify and encode a human homolog of rat elastase IV (HEIV) expressed in pancreas tissue. The present invention also provides for antisense molecules to the nucleotide sequences which encode HEIV, hybridization probes or oligonucleotides for the detection of HEIV-encoding nucleotide sequences, and a diagnostic test based on HEIV-encoding nucleic acid molecules. The present invention further provides for genetically engineered host cells for the expression of HEIV, biologically active HEIV, antibodies capable for binding specifically to HEIV, and treatment methods comprising administration of compounds, such antibodies or inhibitors, capable of binding HEIV to alter its activity.
    • 本发明提供了鉴定和编码在胰腺组织中表达的大鼠弹性蛋白酶IV(HEIV)的人同源物的核苷酸和氨基酸序列。 本发明还提供编码用于检测编码HEIV的核苷酸序列的HEIV,杂交探针或寡核苷酸的核苷酸序列的反义分子,以及基于编码HEIV的核酸分子的诊断测试。 本发明还提供用于表达HEIV,生物活性HEIV,能够特异性结合HEIV的抗体的基因工程宿主细胞,以及包含能够结合HEIV以改变其活性的化合物,例如抗体或抑制剂的治疗方法。